Literature DB >> 7229957

Comparative bioavailability of three commercial acetaminophen tablets.

J B Sotiropoulus, T Deutsch, F M Plakogiannis.   

Abstract

Four different acetaminophen products (three tablets and one liquid) were evaluated for their in vitro properties and in vivo comparative bioavailability. The in vivo properties included assay, hardness, thickness, friability, weight variation, content uniformity, disintegration, and dissolution. A statistically significant variation was observed in friability, disintegration, and dissolution. The dissolution rates were determined in 0.1 N HCl under sink conditions, and the T50% value for Brand A was 50 min while the values for Brands B and C were 1 min. The in vivo evaluation was completed in four subjects with a urinary excretion experiment using a crossover design. The calculated elimination half-lives were 4.12, 2.77, 3.14. amd 2 h for Brands A, B, and C and the standard, respectively. The relative bioavailabilities (with respect to solution) were 82, 87, and 92% for Brands A, B, and C, respectively. The mean amount excreted with Brand A was less than the reference at all time points, although it was not significant. Comparison of the in vitro and in vivo data for the three tablets indicated that the rate and amount of acetaminophen excreted may be related to the dissolution rate.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7229957     DOI: 10.1002/jps.2600700420

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  An attempt to establish an in vitro-in vivo correlation: case of paracetamol immediate-release tablets.

Authors:  J Radovanović; Z Durić; M Jovanović; S Ibrić; M Petrović
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Jan-Mar       Impact factor: 2.441

2.  Bioavailability study of paracetamol tablets in saliva and urine.

Authors:  P Retaco; M González; M T Pizzorno; M G Volonté
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Oct-Dec       Impact factor: 2.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.